These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9222089)

  • 1. Antiproliferative effect of retinoic acid in 1% sodium hyaluronate in an animal model of PVR.
    Takahashi M; Refojo MF; Nakagawa M; Veloso A; Leong FL
    Curr Eye Res; 1997 Jul; 16(7):703-9. PubMed ID: 9222089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoic acid in silicone and silicone-fluorosilicone copolymer oils in a rabbit model of proliferative vitreoretinopathy.
    Nakagawa M; Refojo MF; Marin JF; Doi M; Tolentino FI
    Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2388-95. PubMed ID: 7591628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiproliferative effect of retinoic acid in intravitreous silicone oil in an animal model of proliferative vitreoretinopathy.
    Araiz JJ; Refojo MF; Arroyo MH; Leong FL; Albert DM; Tolentino FI
    Invest Ophthalmol Vis Sci; 1993 Mar; 34(3):522-30. PubMed ID: 8449673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 13-cis-retinoic acid in silicone-fluorosilicone copolymer oil in a rabbit model of proliferative vitreoretinopathy.
    Veloso AA; Kadrmas EF; Larrosa JM; Sandberg MA; Tolentino FI; Refojo MF
    Exp Eye Res; 1997 Sep; 65(3):425-34. PubMed ID: 9299179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiproliferative effect of intravitreal alpha-tocopherol and alpha-tocopheryl-acid-succinate in a rabbit model of PVR.
    Larrosa JM; Veloso AA; Leong FL; Refojo MF
    Curr Eye Res; 1997 Oct; 16(10):1030-5. PubMed ID: 9330855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiproliferative effect of sustained drug delivery system of all-trans retinoic acid implant into rabbit's vitreous cavity for treatment of proliferative vitreoretinopathy].
    Yan XR; Dong XG; Chen N; Wang W
    Zhonghua Yan Ke Za Zhi; 2003 Oct; 39(10):621-5. PubMed ID: 14766078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained delivery of retinoic acid from microspheres of biodegradable polymer in PVR.
    Giordano GG; Refojo MF; Arroyo MH
    Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2743-51. PubMed ID: 8344796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal drug delivery system of all-trans retinoic acid.
    Dong X; Chen N; Xie L; Wang S
    Retina; 2006 Feb; 26(2):210-3. PubMed ID: 16467680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antidepressant hypericin inhibits progression of experimental proliferative vitreoretinopathy.
    Tahara YR; Sakamoto TR; Oshima YR; Ishibashi TR; Inomata HR; Murata TR; Hinton DR; Ryan SJ
    Curr Eye Res; 1999 Oct; 19(4):323-9. PubMed ID: 10520228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of retinotomy in an experimental rabbit model of proliferative vitreoretinopathy.
    Goldaracena MB; Garcia-Layana A; Pastor JC; Saornil MA; de la Fuente F; Gayoso MJ
    Curr Eye Res; 1997 May; 16(5):422-7. PubMed ID: 9154379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of experimental proliferative vitreoretinopathy by retroviral vector-mediated transfer of suicide gene. Can proliferative vitreoretinopathy be a target of gene therapy?
    Sakamoto T; Kimura H; Scuric Z; Spee C; Gordon EM; Hinton DR; Anderson WF; Ryan SJ
    Ophthalmology; 1995 Oct; 102(10):1417-24. PubMed ID: 9097787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene transfer of soluble TGF-beta type II receptor inhibits experimental proliferative vitreoretinopathy.
    Oshima Y; Sakamoto T; Hisatomi T; Tsutsumi C; Ueno H; Ishibashi T
    Gene Ther; 2002 Sep; 9(18):1214-20. PubMed ID: 12215888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribozyme to proliferating cell nuclear antigen to treat proliferative vitreoretinopathy.
    Mandava N; Blackburn P; Paul DB; Wilson MW; Read SB; Alspaugh E; Tritz R; Barber JR; Robbins JM; Kruse CA
    Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3338-48. PubMed ID: 12356843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable biodegradable polymeric device in the treatment of experimental proliferative vitreoretinopathy.
    Hashizoe M; Ogura Y; Takanashi T; Kunou N; Honda Y; Ikada Y
    Curr Eye Res; 1995 Jun; 14(6):473-7. PubMed ID: 7671629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of caffeic acid phenethyl ester and cortisone may prevent proliferative vitreoretinopathy.
    Turkoz Y; Er H; Borazan M; Yilmaz H; Mizrak B; Parlakpinar H; Cigremis Y
    Mediators Inflamm; 2004 Apr; 13(2):127-30. PubMed ID: 15203555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral 13-cis-retinoic acid treatment on postoperative clinical outcome of eyes with proliferative vitreoretinopathy.
    Chang YC; Hu DN; Wu WC
    Am J Ophthalmol; 2008 Sep; 146(3):440-446. PubMed ID: 18599016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantation of fibroblasts into vitrectomized eyes. Dose-response relationship and the putative inhibitory effect of sodium hyaluronate.
    Algvere P; Landau IM
    Ophthalmic Res; 1987; 19(5):271-6. PubMed ID: 3438045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of experimental proliferative vitreoretinopathy with protein kinase C inhibitor (chelerythrine chloride) and melatonin.
    Er H; Turkoz Y; Mizrak B; Parlakpinar H
    Ophthalmologica; 2006; 220(1):17-22. PubMed ID: 16374044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of Ozurdex® (Dexamethasone Intravitreal Implant) on Experimental Proliferative Vitreoretinopathy.
    Kuo HK; Chen YH; Wu PC; Kuo YH
    Ophthalmologica; 2015; 233(3-4):198-203. PubMed ID: 25721986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiproliferative effect of mitomycin C on experimental proliferative vitreoretinopathy in rabbits.
    Yu HG; Chung H
    Korean J Ophthalmol; 1997 Dec; 11(2):98-105. PubMed ID: 9510652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.